Case 10

A 69-year-old man presented with a perirectal lesion and was found to have severe anemia in the course of evaluation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Tax calculation will be finalised at checkout

Purchases are for personal use only

Unable to display preview. Download preview PDF.

Melchert M, Kale V, List A. The role of lenalidomide in the treatment of patients with chromosome 5q deletion and other myelodysplastic syndromes. Curr Opin Hematol 2007;14:123–129.
Article CAS PubMed Google Scholar
van den Berghe H, Michaux. 5q–, twenty-five years later: A synopsis. Cancer Genet Cytogenet 1997;94:1–7.
Article PubMed Google Scholar
Hasserjian RP, Le Beau MM, List AF, et al. Myelodysplastic syndrome with isolated del(5q), In Swerdlow SH, Campo E, Harris NL, et al. eds., WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France, IARC Press, 2008, 102.
Google Scholar
Giagoundidis AAN, Germing U, Aul C. Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies. Clin Cancer Res 2006;12:5–10.
Article Google Scholar
Nimer SD. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q. J Clin Oncol 2006;24:2576–2582.
Article CAS PubMed Google Scholar
Kelaidi C, Eclache V, Fenaux P. The role of lenalidomide in the management of myelodysplasia with del 5q. Br J Haematol 2008;140:267–278.
Article CAS PubMed Google Scholar
Nimer SD, Golde DW. The 5q– abnormality. Blood 1987;70:1705–1712.
Google Scholar

Director of Hematopathology and Flow Cytometry Pathology and Laboratory Medicine Service Veterans Affairs Medical Center Eastern Colorado Health Care System Professor of Pathology Department of Pathology, University of Colorado School of Medicine, 80220, Denver, Colorado, USA
Tsieh Sun M.D.

(2009). Case 10. In: Sun, T. (eds) Atlas of Hematologic Neoplasms. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-89848-3_11